Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
George Georgiou
University of Texas, Austin, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Orros Biotherapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Covered Individual is founder and manager of Orros Biotherapeutics, LLC, a start-up company pursuing the discovery of antibody therapeutics. The Covered Individual holds equity ownership in the company. Orros Biotherapeutics has the option to license university-owned IP where the CI is co-inventor. The CI continues to carry out funded research that is related to this IP/technology. The results of this research could potentially impact the value of the IP or could potentially attract investor interest in the company.
Molecular Analysis of Serum Antibody Constituents in Zika Virus Infection
Project Narrative The rapid global explosion of the number of Zika virus infections signals an urgency to identify therapeutics. This project aims to assess and quantify the persistence of specific and protective antibodies as well as cross- reactive (possible pathogenic) antibodies in Zika-infected patient blood. The antibodies described here could lead to rapid development of new therapeutics and aid the design of a future vaccine against Zika virus.
Filed on February 14, 2019.
Tell us what you know about George Georgiou's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
George Georgiou filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| George Georgiou | University of Texas, Austin | Conflict of Interest | Aeglea Biotherapeutics | >$600,000 |
| George Georgiou | University of Texas, Austin | Conflict of Interest | Aeglea Biotherapeutics | $0 - $4,999 |
| George Georgiou | University of Texas, Austin | Conflict of Interest | GMA, LLC | Value cannot be readily determined |
| George Georgiou | University of Texas, Austin | Conflict of Interest | Aeglea, LLC. | Value cannot be readily determined |
| George Georgiou | University of Texas, Austin | Conflict of Interest | Aeglea, LLC. | Value cannot be readily determined |
Other search results for: “George Georgiou”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| George Georgiou | University of Texas, Austin | Financial Disclosure | Aeglea Biotherapeutics, LLC |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.